Managing Febrile Respiratory Illnesses during Hypothetical SARS Outbreaks
Since the World Health Organization declared the global outbreak of severe acute respiratory syndrome (SARS) contained in July 2003, new cases have periodically reemerged in Asia. This situation has placed hospitals and health officials worldwide on heightened alert. In a future outbreak, rapidly an...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2005-02-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/11/2/04-0524_article |
id |
doaj-0b2fa18792c240119695e7e28b4b5936 |
---|---|
record_format |
Article |
spelling |
doaj-0b2fa18792c240119695e7e28b4b59362020-11-25T02:13:58ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592005-02-0111219120010.3201/eid1102.040524Managing Febrile Respiratory Illnesses during Hypothetical SARS OutbreaksKamran KhanPeter MuennigMichael GardamJoshua Graff ZivinSince the World Health Organization declared the global outbreak of severe acute respiratory syndrome (SARS) contained in July 2003, new cases have periodically reemerged in Asia. This situation has placed hospitals and health officials worldwide on heightened alert. In a future outbreak, rapidly and accurately distinguishing SARS from other common febrile respiratory illnesses (FRIs) could be difficult. We constructed a decision-analysis model to identify the most efficient strategies for managing undifferentiated FRIs within a hypothetical SARS outbreak in New York City during the season of respiratory infections. If establishing reliable epidemiologic links were not possible, societal costs would exceed $2.0 billion per month. SARS testing with existing polymerase chain reaction assays would have harmful public health and economic consequences if SARS made up <0.1% of circulating FRIs. Increasing influenza vaccination rates among the general population before the onset of respiratory season would save both money and lives.https://wwwnc.cdc.gov/eid/article/11/2/04-0524_articleSevere Acute Respiratory SyndromeInfluenza-Like-IllnessInfluenza VaccinationMass ScreeningCost-Benefit AnalysisHuman |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kamran Khan Peter Muennig Michael Gardam Joshua Graff Zivin |
spellingShingle |
Kamran Khan Peter Muennig Michael Gardam Joshua Graff Zivin Managing Febrile Respiratory Illnesses during Hypothetical SARS Outbreaks Emerging Infectious Diseases Severe Acute Respiratory Syndrome Influenza-Like-Illness Influenza Vaccination Mass Screening Cost-Benefit Analysis Human |
author_facet |
Kamran Khan Peter Muennig Michael Gardam Joshua Graff Zivin |
author_sort |
Kamran Khan |
title |
Managing Febrile Respiratory Illnesses during Hypothetical SARS Outbreaks |
title_short |
Managing Febrile Respiratory Illnesses during Hypothetical SARS Outbreaks |
title_full |
Managing Febrile Respiratory Illnesses during Hypothetical SARS Outbreaks |
title_fullStr |
Managing Febrile Respiratory Illnesses during Hypothetical SARS Outbreaks |
title_full_unstemmed |
Managing Febrile Respiratory Illnesses during Hypothetical SARS Outbreaks |
title_sort |
managing febrile respiratory illnesses during hypothetical sars outbreaks |
publisher |
Centers for Disease Control and Prevention |
series |
Emerging Infectious Diseases |
issn |
1080-6040 1080-6059 |
publishDate |
2005-02-01 |
description |
Since the World Health Organization declared the global outbreak of severe acute respiratory syndrome (SARS) contained in July 2003, new cases have periodically reemerged in Asia. This situation has placed hospitals and health officials worldwide on heightened alert. In a future outbreak, rapidly and accurately distinguishing SARS from other common febrile respiratory illnesses (FRIs) could be difficult. We constructed a decision-analysis model to identify the most efficient strategies for managing undifferentiated FRIs within a hypothetical SARS outbreak in New York City during the season of respiratory infections. If establishing reliable epidemiologic links were not possible, societal costs would exceed $2.0 billion per month. SARS testing with existing polymerase chain reaction assays would have harmful public health and economic consequences if SARS made up <0.1% of circulating FRIs. Increasing influenza vaccination rates among the general population before the onset of respiratory season would save both money and lives. |
topic |
Severe Acute Respiratory Syndrome Influenza-Like-Illness Influenza Vaccination Mass Screening Cost-Benefit Analysis Human |
url |
https://wwwnc.cdc.gov/eid/article/11/2/04-0524_article |
work_keys_str_mv |
AT kamrankhan managingfebrilerespiratoryillnessesduringhypotheticalsarsoutbreaks AT petermuennig managingfebrilerespiratoryillnessesduringhypotheticalsarsoutbreaks AT michaelgardam managingfebrilerespiratoryillnessesduringhypotheticalsarsoutbreaks AT joshuagraffzivin managingfebrilerespiratoryillnessesduringhypotheticalsarsoutbreaks |
_version_ |
1724902904688541696 |